<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1395rr" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1395rr/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1395rr/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1395rr"><akn:num>1395rr</akn:num><akn:heading>End stage renal disease program</akn:heading><akn:content><akn:p>§ 1395rr. End stage renal disease program(a) Type, duration, and scope of benefitsThe benefits provided by parts A and B of this subchapter shall include benefits for individuals who have been determined to have end stage renal disease as provided in section 426–1 of this title, and benefits for kidney donors as provided in subsection (d) of this section. Notwithstanding any other provision of this subchapter, the type, duration, and scope of the benefit provided by parts A and B with respect to individuals who have been determined to have end stage renal disease and who are entitled to such benefits without regard to section 426–1 of this title shall in no case be less than the type, duration, and scope of the benefits so provided for individuals entitled to such benefits solely by reason of that section.


(b) Payments with respect to services; dialysis; regulations; physicians’ services; target reimbursement rates; home dialysis supplies and equipment; self-care home dialysis support services; self-care dialysis units; hepatitis B vaccine(1) Payments under this subchapter with respect to services, in addition to services for which payment would otherwise be made under this subchapter, furnished to individuals who have been determined to have end stage renal disease shall include (A) payments on behalf of such individuals to providers of services and renal dialysis facilities which meet such requirements as the Secretary shall by regulation prescribe for institutional dialysis services and supplies (including self-dialysis services in a self-care dialysis unit maintained by the provider or facility), transplantation services, self-care home dialysis support services which are furnished by the provider or facility, and routine professional services performed by a physician during a maintenance dialysis episode if payments for his other professional services furnished to an individual who has end stage renal disease are made on the basis specified in paragraph (3)(A</akn:p></akn:content><akn:subsection eId="subsec_1395rr_a"><akn:num>(a)</akn:num><akn:heading>Type, duration, and scope of benefits</akn:heading><akn:content><akn:p>(a) Type, duration, and scope of benefits The benefits provided by parts A and B of this subchapter shall include benefits for individuals who have been determined to have end stage renal disease as provided in section 426–1 of this title, and benefits for kidney donors as provided in subsection (d) of this section. Notwithstanding any other provision of this subchapter, the type, duration, and scope of the benefit provided by parts A and B with respect to individuals who have been determined to have end stage renal disease and who are entitled to such benefits without regard to section 426–1 of this title shall in no case be less than the type, duration, and scope of the benefits so provided for individuals entitled to such benefits solely by reason of that section.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_b"><akn:num>(b)</akn:num><akn:heading>Payments with respect to services; dialysis; regulations; physicians’ services; target reimbursement rates; home dialysis supplies and equipment; self-care home dialysis support services; self-care dialysis units; hepatitis B vaccine</akn:heading><akn:content><akn:p>(b) Payments with respect to services; dialysis; regulations; physicians’ services; target reimbursement rates; home dialysis supplies and equipment; self-care home dialysis support services; self-care dialysis units; hepatitis B vaccine</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_c"><akn:num>(c)</akn:num><akn:heading>Renal disease network areas; coordinating councils, executive committees, and medical review boards; national end stage renal disease medical information system; functions of network organizations</akn:heading><akn:content><akn:p>(c) Renal disease network areas; coordinating councils, executive committees, and medical review boards; national end stage renal disease medical information system; functions of network organizations</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_d"><akn:num>(d)</akn:num><akn:heading>Donors of kidney for transplant surgery</akn:heading><akn:content><akn:p>(d) Donors of kidney for transplant surgery Notwithstanding any provision to the contrary in section 426 of this title any individual who donates a kidney for transplant surgery shall be entitled to benefits under parts A and B of this subchapter with respect to such donation. Reimbursement for the reasonable expenses incurred by such an individual with respect to a kidney donation shall be made (without regard to the deductible, premium, and coinsurance provisions of this subchapter), in such manner as may be prescribed by the Secretary in regulations, for all reasonable preparatory, operation, and postoperation recovery expenses associated with such donation, including but not limited to the expenses for which payment could be made if he were an eligible individual for purposes of parts A and B of this subchapter without regard to this subsection. Payments for postoperation recovery expenses shall be limited to the actual period of recovery.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_e"><akn:num>(e)</akn:num><akn:heading>Reimbursement of providers, facilities, and nonprofit entities for costs of artificial kidney and automated dialysis peritoneal machines for home dialysis</akn:heading><akn:content><akn:p>(e) Reimbursement of providers, facilities, and nonprofit entities for costs of artificial kidney and automated dialysis peritoneal machines for home dialysis</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_f"><akn:num>(f)</akn:num><akn:heading>Experiments, studies, and pilot projects</akn:heading><akn:content><akn:p>(f) Experiments, studies, and pilot projects</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_g"><akn:num>(g)</akn:num><akn:heading>Conditional approval of dialysis facilities; restriction-of-payments notice to public and facility; notice and hearing; judicial review</akn:heading><akn:content><akn:p>(g) Conditional approval of dialysis facilities; restriction-of-payments notice to public and facility; notice and hearing; judicial review</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395rr_h"><akn:num>(h)</akn:num><akn:heading>Quality incentives in the end-stage renal disease program</akn:heading><akn:content><akn:p>(h) Quality incentives in the end-stage renal disease program</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>